DSS
HWH
AEI
IBO

Heng Fai Ambrose Chan

Known title: Chief Executive OfficerCIK: 0001261725

Heng Fai Ambrose Chan's purchase track record

How the stock did after each of Heng Fai Ambrose Chan's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
27
of 28 since September 8, 2021
Stock higher 6 months later
33%
3 months: 32%
Median 6-month return
-25.9%
3 months: -12.9%
Beat the S&P 500
30%
median -27.6% vs. index
PurchaseStockAmount3 months6 months
6/8/2026AEI$500K-7.0%pending
8/18/2025AEI$43K+75.4%+82.8%
2/6/2025AEI$377K0.0%+17.0%
1/22/2025AEI$136K+8.6%+64.1%
12/24/2024AEI$585K+1.9%+6.8%
12/10/2024AEI$1000K-27.6%-20.4%
11/25/2024AEI$3.00M-8.0%-29.2%
9/24/2024AEI$3.80M-15.7%-14.2%
8/16/2024AEI$44K+15.7%+17.9%
6/20/2024AEI$292K+3.9%-17.8%
6/11/2024AEI$227K-10.8%+6.6%
6/3/2024AEI$124K+18.4%+14.6%
5/24/2024AEI$533K+116.4%+61.2%
12/28/2023DSS$98K-37.6%-39.5%
8/2/2023HWH$460K+47.1%-83.5%
6/28/2023AEI$34K-14.7%-44.8%
5/30/2023AEI$361K-28.8%-38.0%
5/19/2023AEI$7K-11.1%-11.8%
2/8/2023AEI$1.20M-21.4%-25.9%
12/16/2022AEI$189K-57.0%-52.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

this person other insiders at DSS
this person other insiders at HWH

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

Alset AI Announces FingerMotion and Lyken AI Partnerships. Alset AI highlighted a new infrastructure agreement with FingerMotion in Alberta and a strategic alignment with Lyken AI. These developments focus on expanding the company's AI infrastructure capabilities. The stock is currently trading near its 52-week low, reflecting recent volatility.

this person other insiders at AEI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Impact BioMedical (IBO) noted in after‑hours health‑care stock moves. IBO was listed among twelve health‑care companies that showed price movement in Wednesday’s after‑market session, according to Benzinga. The activity highlights recent investor interest in the stock. The move occurs while the share trades near its recent support level of $0.47.

this person other insiders at IBO

Transaction History

DSS▼ Sell$18K
HWH▲ Buy—
AEI▼ Sell—
AEI▲ Buy$500K
AEI▼ Sell$99K
HWH▲ Buy—
AEI▼ Sell$1.3M
DSS▼ Sell$176K
AEI▲ Buy$43K
AEI▼ Sell—
AEI▲ Buy—
AEI▲ Buy—
IBO▼ Sell$173K
IBO▼ Sell$213K
IBO▼ Sell$204K
IBO▼ Sell$174K
IBO▼ Sell$174K
IBO▼ Sell$135K
IBO▼ Sell$2K
IBO▼ Sell$223K
IBO▼ Sell$393K
IBO▼ Sell$941K
IBO▼ Sell$1.3M
IBO▼ Sell$308K
AEI▼ Sell—
AEI▲ Buy$62K
AEI▲ Buy$22K
AEI▲ Buy$155K
AEI▲ Buy$140K
DSS▲ Buy$0
AEI▲ Buy$93K
AEI▲ Buy$43K
AEI▲ Buy$585K
AEI▲ Buy$800K
AEI▲ Buy$200K
AEI▲ Buy$3.0M
AEI▲ Buy$3.5M
AEI▲ Buy$300K
AEI▲ Buy$15K
AEI▲ Buy$3K
AEI▲ Buy$19K
AEI▲ Buy$7K
AEI▲ Buy$215K
AEI▲ Buy$5K
AEI▲ Buy$2K
AEI▲ Buy$58K
AEI▲ Buy$13K
AEI▲ Buy$60K
AEI▲ Buy$48K
AEI▲ Buy$12K
AEI▲ Buy$89K
AEI▲ Buy$2K
AEI▲ Buy$17K
AEI▲ Buy$8K
AEI▲ Buy$9K
AEI▲ Buy$55K
AEI▲ Buy$8K
AEI▲ Buy$3K
AEI▲ Buy$30K
AEI▲ Buy$12K
AEI▲ Buy$7K
AEI▲ Buy$11K
AEI▲ Buy$153K
AEI▲ Buy$50K
AEI▲ Buy$163K
AEI▲ Buy$149K
HWH▼ Sell—
HWH▼ Sell—
HWH▼ Sell—
HWH▼ Sell—
DSS▲ Buy$98K
HWH▼ Sell$428K
HWH▲ Buy$70
HWH▲ Buy$3K
HWH▲ Buy$38K
HWH▲ Buy$62K
HWH▲ Buy$115K
HWH▲ Buy$30K
HWH▲ Buy$161K
HWH▲ Buy$52K
AEI▲ Buy$17K
AEI▲ Buy$17K
AEI▲ Buy$196K
AEI▲ Buy$165K
AEI▲ Buy$7K
AEI▲ Buy$1.2M
AEI▲ Buy$59K
AEI▲ Buy$116K
AEI▲ Buy$14K
DSS▲ Buy$76K
DSS▲ Buy$10K
AEI▲ Buy$118K
AEI▲ Buy$33K
AEI▲ Buy$87K
AEI▲ Buy$57K
AEI▲ Buy$54K
AEI▲ Buy$52K
AEI▲ Buy$7K
AEI▲ Buy$251K
AEI▼ Sell—
DSS▼ Sell—
DSS▲ Buy—
DSS▲ Buy—
AEI▲ Buy$112K
AEI▲ Buy$247K
AEI▲ Buy$3.0M
AEI▲ Buy$187K
AEI▲ Buy$494K
AEI▲ Buy$1.0M
DSS▲ Buy—
AEI▲ Buy$501K
DSS▲ Buy$1.5M
AEI▼ Sell$6.3M
AEI▲ Buy$4.4M
DSS▲ Buy$15.0M

We use analytics to understand how market-wall is used. No personal data is sold.